Home » Topics » Regulatory » Patents

Patents
RSS

Series of dopamine receptor subtype-selective ligands developed at Pfizer

June 5, 1998

Synthelabo discloses new agents for urinary incontinence

June 5, 1998

Cryptophycins for cancer, fungal infections described in patent literature

June 5, 1998

Novel series of 5-HT1F agonists under study at Lilly

June 5, 1998

Neurokinin antagonists in the pipeline at Schering-Plough

June 4, 1998

Another group of CRF antagonists for stress-related disorders in development at Pfizer

June 4, 1998

More work at P&G on metalloprotease inhibitors

June 4, 1998

Byk Gulden's new PDE IV inhibitors

June 4, 1998

Dopaminergic agents for schizophrenia described by AHP

June 4, 1998

Genetics Institute claims series with PLA2-inhibitory activity

June 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...